首頁 > 市場調查報告書 > 製藥

DDS

市場調查報告書

商品編碼

1477215

脂質體藥物傳遞市場、副產品、技術、適應症、最終用戶、地理位置

Liposome Drug Delivery Market, By Product, By Technology, By Indication, By End User, By Geography

出版日期: 2024年04月10日 | 出版商:

Coherent Market Insights | 英文 175 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

脂質體給藥市場預計到2024年將達到54.822億美元，預計到2031年將達到99.356億美元，2024年至2031年的年複合成長率（CAGR）為8.9%。

報告範圍		報告詳情
基準年：	2023年	2024 年市場規模：	54.822 億美元
歷史數據：	2019年至2023年	預測期：	2024年至2031年
預測 2024 年至 2031 年複合年成長率：	8.90%	2031 年價值預測：	99.356 億美元

數字。 2024 年依地區分類的脂質體藥物傳遞市場佔有率 (%)

脂質體藥物遞送是一種有前途的標靶藥物遞送和釋放方法。脂質體是人工製備的囊泡，由類似細胞膜的脂質雙層組成，可以將疏水性和親水性藥物分別封裝在其水性核心和脂質膜內。這使得脂質體能夠作為奈米載體，將各種治療劑輸送到目標部位，增強其療效和生物利用度，同時減少對健康組織的毒性。脂質體製劑的最新進展提高了藥物負載能力、血液循環穩定性以及主動或被動靶向能力，使其成為抗癌藥物、疫苗、基因療法等遞送的潛在候選者。

市場動態：

全球脂質體藥物傳遞市場的推動因素包括癌症和其他慢性疾病盛行率的上升、對標靶藥物傳遞系統的需求不斷增加以及奈米醫學和生物製藥領域主要參與者不斷增加的研發投資。然而，與藥物開發和法規核准相關的高成本繼續限制更廣泛的市場採用。人們對個人化醫療和基於奈米技術的製劑的興趣日益濃厚，為脂質體藥物製造商提供了重大機會。製藥商和脂質體技術提供者之間的策略合作正在幫助將治療應用擴展到傳染病、疼痛管理和自體免疫疾病等領域。

研究的主要特點：

該報告對全球脂質體給藥市場進行了深入分析，並提供了以2023年為基準年的預測期（2024-2031年）的市場規模（百萬美元）和年複合成長率（CAGR%）。
它闡明了不同區隔市場的潛在收入成長機會，並解釋了該市場有吸引力的投資主張矩陣。
這項研究還提供了有關市場促進因素、限制因素、機會、新產品發布或批准、市場趨勢、區域前景以及主要參與者採取的競爭策略的重要見解。
它根據以下參數描述了全球脂質體藥物輸送市場的主要參與者——公司亮點、產品組合、主要亮點、財務表現和策略。
該報告的見解將使行銷人員和公司管理當局能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
全球脂質體藥物傳輸市場迎合了該行業的各種利益相關者，包括投資者、供應商、產品製造商、分銷商、新進業者和金融分析師。
利害關係人可以透過用於分析全球脂質體藥物輸送市場的各種策略矩陣輕鬆做出決策。

介紹
北美洲
美國
加拿大
拉丁美洲
巴西
墨西哥
阿根廷
拉丁美洲其他地區
歐洲
介紹
市場規模和預測以及同比成長（依產品）（百萬美元）
依技術分類的市場規模和預測以及同比成長（百萬美元）
市場規模和預測以及同比成長（依指標）（百萬美元）
市場規模和預測以及同比成長（依最終用戶）（百萬美元）
依國家/地區分類的市場規模和預測以及同比成長（百萬美元）
英國
德國
義大利
法國
西班牙
俄羅斯
歐洲其他地區
亞太地區
介紹
市場規模和預測以及同比成長（依產品）（百萬美元）
依技術分類的市場規模和預測以及同比成長（百萬美元）
市場規模和預測以及同比成長（依指標）（百萬美元）
市場規模和預測以及同比成長（依最終用戶）（百萬美元）
依國家/地區分類的市場規模和預測以及同比成長（百萬美元）
中國
印度
日本
東協
澳洲
韓國
亞太地區其他地區
中東
介紹
市場規模和預測以及同比成長（依產品）（百萬美元）
依技術分類的市場規模和預測以及同比成長（百萬美元）
市場規模和預測以及同比成長（依指標）（百萬美元）
市場規模和預測以及同比成長（依最終用戶）（百萬美元）
依國家/地區分類的市場規模和預測以及同比成長（百萬美元）
海灣合作理事會
以色列
中東其他地區
非洲
介紹
市場規模和預測以及同比成長（依產品）（百萬美元）
依技術分類的市場規模和預測以及同比成長（百萬美元）
市場規模和預測以及同比成長（依指標）（百萬美元）
市場規模和預測以及同比成長（依最終用戶）（百萬美元）
依國家/地區分類的市場規模和預測以及同比成長（百萬美元）
北非
中非
南非

第 10 章：競爭格局

公司簡介
吉利德科學公司
綠葉製藥集團
易普森生物製藥股份有限公司
帕西拉製藥公司
阿奎塔斯治療公司
脂質體公司
武田藥品工業株式會社
台灣脂質體股份有限公司
遠藤國際
爵士製藥公司

第 11 章：分析師觀點

命運之輪
分析師觀點
連貫的機會圖

第 12 章：參考文獻與研究方法

參考
研究方法論

簡介目錄

Product Code: CMI6883

The liposome drug delivery market is estimated to be valued at USD 5,482.2 Mn in 2024 and is expected to reach USD 9,935.6 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 8.9% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2024:	US$ 5,482.2 Mn
Historical Data for:	2019 To 2023	Forecast Period:	2024 To 2031
Forecast Period 2024 to 2031 CAGR:	8.90%	2031 Value Projection:	US$ 9,935.6 Mn

Figure. Liposome Drug Delivery Market Share (%), By Region 2024

Liposome drug delivery is a promising approach for targeted drug delivery and release. Liposomes are artificially prepared vesicles made up of lipid bilayers similar to cell membranes that can encapsulate both hydrophobic and hydrophilic drugs within their aqueous core and lipid membranes respectively. This enables liposomes to serve as nanocarriers for the delivery of various therapeutic agents to target sites, enhancing their efficacy and bioavailability while reducing toxicity to healthy tissues. Recent advancements in liposomal formulations have improved drug loading capacity, stability in blood circulation as well as active or passive targeting capabilities, making them potential candidates for delivery of anti-cancer drugs, vaccines, gene therapies, and others.

Market Dynamics:

The global liposome drug delivery market is driven by the rising prevalence of cancer and other chronic diseases, increasing demand for targeted drug delivery systems, and growing R&D investments from key players in the nanomedicine and biopharma sectors. However, high costs associated with drug development and regulatory approvals continue to restrain broader market adoption. Growing interest in personalized medicine and nanotechnology-based formulations present significant opportunities for liposome drugs manufacturers. Strategic collaborations between drug makers and liposome technology providers are helping expand therapeutic applications into areas such as infectious diseases, pain management, and autoimmune disorders.

Key Features of the Study:

This report provides an in-depth analysis of the global liposome drug delivery market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global liposome drug delivery market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Gilead Sciences, Inc., Luye Pharma Group, Ipsen Biopharmaceuticals, Inc., Pacira Pharmaceuticals, Inc., Acuitas Therapeutics, LIPOSOMA B.V., Takeda Pharmaceutical Company Limited, Taiwan Liposome Company, Ltd., Endo International, and Jazz Pharmaceuticals plc
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global liposome drug delivery market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global liposome drug delivery market

Detailed Segmentation-

Product:
- Liposomal Paclitaxel
- Liposomal Doxorubicin
- Liposomal Amphotericin B
- Others
Technology:
- Stealth Liposome Technology
- Non-PEGylated Liposome Technology
- DepoFoam Liposome Technology
Indication:
- Fungal Diseases
- Pain Management
- Cancer Therapeutics
- Others
End User:
- Hospitals
- Clinics
- Research Laboratories
- Others
Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Gilead Sciences, Inc.
- Luye Pharma Group
- Ipsen Biopharmaceuticals, Inc.
- Pacira Pharmaceuticals, Inc.
- Acuitas Therapeutics
- LIPOSOMA B.V.
- Takeda Pharmaceutical Company Limited
- Taiwan Liposome Company, Ltd.
- Endo International
- Jazz Pharmaceuticals plc

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Product
- Market Snapshot, By Technology
- Market Snapshot, By Indication
- Market Snapshot, By End User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
Recent Developments
Acquisitions and Partnerships Scenario
Regulatory Scenario
Product Launches/Approvals
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Liposome Drug Delivery Market - Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 impact on the market

5. Global Liposome Drug Delivery Market, By Product, 2019 - 2031, (USD Mn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Liposomal Paclitaxel
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Liposomal Doxorubicin
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Liposomal Amphotericin B
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Nasal Endoscopes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

6. Global Liposome Drug Delivery Market, By Technology, 2019 - 2031, (USD Mn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Stealth Liposome Technology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Non-PEGylated Liposome Technology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
DepoFoam Liposome Technology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

7. Global Liposome Drug Delivery Market, By Indication, 2019 - 2031, (USD Mn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Fungal Diseases
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Pain Management
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Cancer Therapeutics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

8. Global Liposome Drug Delivery Market, By End User, 2019 - 2031, (USD Mn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Hospitals
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Clinics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Research Laboratories
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

9. Global Liposome Drug Delivery Market, By Region, 2019 - 2031, (USD Mn)

Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2031
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
U.S.
Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
GCC
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Mn)
North Africa
Central Africa
South Africa